Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 8
1965 10
1966 12
1967 11
1968 2
1969 4
1970 5
1971 7
1972 4
1973 10
1974 30
1975 30
1976 55
1977 28
1978 31
1979 23
1980 17
1981 27
1982 21
1983 20
1984 17
1985 20
1986 16
1987 11
1988 9
1989 18
1990 16
1991 16
1992 21
1993 27
1994 11
1995 19
1996 12
1997 13
1998 14
1999 11
2000 11
2001 17
2002 10
2003 20
2004 16
2005 15
2006 16
2007 15
2008 19
2009 18
2010 19
2011 22
2012 17
2013 12
2014 14
2015 19
2016 17
2017 25
2018 21
2019 13
2020 9
2021 12
2022 8
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

941 results

Results by year

Filters applied: . Clear all
Page 1
Seborrhoeic dermatitis.
Naldi L. Naldi L. BMJ Clin Evid. 2010 Dec 7;2010:1713. BMJ Clin Evid. 2010. PMID: 21418692 Free PMC article. Review.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: bifonazole, emollients, ketoconazole, lithium succinate, selenium sulphide, tar shampoo, terbinafine, and topical corticosteroids (betamethaso
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: bifon …
Betamethasone vigilance.
Field A, Randall C. Field A, et al. Br Dent J. 2021 Sep;231(6):317. doi: 10.1038/s41415-021-3487-9. Br Dent J. 2021. PMID: 34561568 No abstract available.
Steroid addiction.
Kligman AM, Frosch PJ. Kligman AM, et al. Int J Dermatol. 1979 Jan-Feb;18(1):23-31. doi: 10.1111/j.1365-4362.1979.tb01905.x. Int J Dermatol. 1979. PMID: 153891 Review. No abstract available.
Preventive effects of betamethasone valerate ointment for radiation-induced severe oral mucositis in patients with oral or oropharyngeal cancer: protocol for a multicentre, phase II, randomised controlled trial (Bet-ROM study).
Soutome S, Otsuru M, Murata M, Kawashita Y, Yoshimatsu M, Funahara M, Yamamura Y, Hasegawa T, Yamada SI, Kojima Y, Nakahara H, Shibuya Y, Umeda M, Saito T. Soutome S, et al. BMJ Open. 2022 Jan 17;12(1):e056781. doi: 10.1136/bmjopen-2021-056781. BMJ Open. 2022. PMID: 35039301 Free PMC article.
INTRODUCTION: This is a randomised, multi-centre, open-label, phase II study to evaluate the efficacy of betamethasone valerate ointment on radiation-induced oral mucositis in patients with head and neck cancer undergoing concomitant radiotherapy with cisplatin or c …
INTRODUCTION: This is a randomised, multi-centre, open-label, phase II study to evaluate the efficacy of betamethasone valerate
Evaluation of fractional carbon dioxide laser alone versus its combination with betamethasone valerate in treatment of alopecia areata, a clinical and dermoscopic study.
Halim DA, Nayer M, El-Samanoudy SI, Raheem HMA, Ragab N. Halim DA, et al. Arch Dermatol Res. 2023 Apr;315(3):505-511. doi: 10.1007/s00403-022-02393-5. Epub 2022 Sep 17. Arch Dermatol Res. 2023. PMID: 36114868 Free PMC article.
The objective is to evaluate and compare the efficacy and safety of FRCO(2) laser in treatment of AA alone or in combination with betamethasone valerate cream. 30 patients were assigned to one of the following groups, Group A FRCO(2), Group B FRCO(2) plus betamet
The objective is to evaluate and compare the efficacy and safety of FRCO(2) laser in treatment of AA alone or in combination with betamet
Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
El-Ashmawy AA, El-Maadawy IH, El-Maghraby GM. El-Ashmawy AA, et al. J Dermatolog Treat. 2018 Feb;29(1):55-64. doi: 10.1080/09546634.2017.1330527. Epub 2017 Jun 15. J Dermatolog Treat. 2018. PMID: 28521549 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of topical latanoprost, minoxidil and betamethasone valerate on hair growth in patients with AA. PATIENTS AND METHODS: Hundred patients with AA classified into five groups of 20 treated with: Group I, latanoprost 0.1% lo …
OBJECTIVE: To compare the efficacy and safety of topical latanoprost, minoxidil and betamethasone valerate on hair growth in p …
Erosive lichen planus.
Kanatas A, Brotherton P. Kanatas A, et al. Br Dent J. 2014 May;216(10):545. doi: 10.1038/sj.bdj.2014.408. Br Dent J. 2014. PMID: 24852967 No abstract available.
Is half strength of 0.05 % betamethasone valerate cream still effective in the treatment of phimosis in young children?
Sookpotarom P, Asawutmangkul C, Srinithiwat B, Leethochawalit S, Vejchapipat P. Sookpotarom P, et al. Pediatr Surg Int. 2013 Apr;29(4):393-6. doi: 10.1007/s00383-012-3253-9. Pediatr Surg Int. 2013. PMID: 23292538 Clinical Trial.
INTRODUCTION: 0.05 % betamethasone valerate cream is generally used as an alternative to circumcision for the treatment of phimosis in boys. ...CONCLUSIONS: 0.025 % betamethasone valerate cream produced a clinical improvement. However, the half-strengt …
INTRODUCTION: 0.05 % betamethasone valerate cream is generally used as an alternative to circumcision for the treatment of phi …
In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate.
Kubota K, Maibach HI. Kubota K, et al. J Pharm Sci. 1993 Oct;82(10):1039-45. J Pharm Sci. 1993. PMID: 8254489
The percutaneous permeation and sorption isotherm (equilibrium) profiles of betamethasone and betamethasone 17-valerate were estimated in an in vitro study with excised human skin. ...The stratum corneum (dry weight)/water partition coefficient of betameth
The percutaneous permeation and sorption isotherm (equilibrium) profiles of betamethasone and betamethasone 17-valerate
Plasma concentrations of betamethasone after topical application of betamethasone 17-valerate: comparison with oral administration.
Kubota K, Lo ES, Huttinot G, Andersen PH, Maibach HI. Kubota K, et al. Br J Clin Pharmacol. 1994 Jan;37(1):86-8. doi: 10.1111/j.1365-2125.1994.tb04246.x. Br J Clin Pharmacol. 1994. PMID: 8148226 Free PMC article. Clinical Trial.
Plasma concentrations of betamethasone were measured by r.i.a. after oral administration of 0.6 mg betamethasone and topical application of betamethasone 17-valerate in the same five healthy subjects. ...Betamethasone 17-valerate may requ …
Plasma concentrations of betamethasone were measured by r.i.a. after oral administration of 0.6 mg betamethasone and topical a …
941 results